0.05Open0.05Pre Close0 Volume1.98K Open Interest5.00Strike Price0.00Turnover224.33%IV54.91%PremiumJul 19, 2024Expiry Date0.00Intrinsic Value100Multiplier7DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type0.1141Delta0.1890Gamma65.20Leverage Ratio-0.0134Theta0.0001Rho7.44Eff Leverage0.0009Vega
CureVac Stock Discussion
Benzinga· 1 min ago
New trial date for U.S. patent litigation set for March 3, 2025, following settlement with Acuitas Therapeutics.
First instance decision on validity of EP 3 708 668 B1 (split poly-A tail technology) scheduled for March 25, 2025, by European Patent Office in the context of the German patent liti...
loading...
No comment yet